A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition. By Caroline Hopkins Legaspi Tens of millions of people in the United States struggle with ...

This is Everyday Science with Clare Wilson, a subscriber-only newsletter from The i Paper. If you’d like to get this direct to your inbox, every single week, y ou can sign up here. Hello, and welcome ...